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Chemical Synthesis
General: Unless otherwise stated, all reagents were commercially available and were used as supplied, without further purification. HPLC purities were found to be ≥95% in all cases. Mass spectroscopy was carried out on a Shimadzu LCMS-2010 EV using electrospray ionisation conditions. and extracted with ethyl acetate (3 x 20 mL); the combined organic extracts were then dried over Na 2 SO 4 and concentrated under reduced pressure. The crude residue was purified by gradient flash chromatography or preparative HPLC.
The LCMS analysis described in this Supporting
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The following compounds were prepared according to this procedure: Rats were re tested 60 minutes later in the same fashion.
In Vitro ADME Kinetic solubility, rat microsomal stability and plasma protein binding assays were performed by BioFocus (Cambridge, U.K.).
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Kinetic solubility.
Using a 10 mM stock solution of each compound in 100% DMSO, dilutions were prepared to a theoretical concentration of 50 μM in both Phosphate Buffered Saline (PBS), pH 7.4 (2% DMSO final) and in 100% DMSO and allowed to equilibrate at room temperature on an orbital shaker for two hours. The PBS dilutions were filtered and filtrate was analysed by LC-UV and LC-MS and compared to the DMSO dilutions to determine solubility.
Microsomal stability.
Test compounds (1 μM) were incluabted with pooled microsomes (0.25 mg protein/mL) at 37 ºC for various time points. The reaction was terminated by addition of 100 μL of acetonitrile containing carbamazepine as analytical internal standard. Samples were centrifuged and the supernatant fractions analysed by LC-MS/MS to determine the percentage of compound remaining. Natural log plots of the % remaining were used to determine the half-life of the parent compounds.
Plasma protein binding.
Test compounds (10 μM) were added to rat plasma and dialysed against PBS (pH 7.4) for 6 hours at 37 ºC. After incubation the contents of each plasma and buffer compartment were removed and mixed with equal volumes of control buffer or plasma as appropriate to maintain matrix equivalence for analysis. Plasma proteins were then precipitated by the addition of acetonitrile containing carbamazepine as analytical internal standard, centrifuged and the supernatant removed for analysis by mass spectrometry (LC-MS/MS) to determine the percentage of drug bound.
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Computational chemistry.
Homology models were constructed from the avian β 1 adrenergic GPCR crystal structure bound to cyanopindolol (PDB: 2VT4). 1, 2 Owing to the relatively low percentage identity between the two proteins (25% overall, less than 20% around the ligand binding site), two initial homology models of the adenosine A 2A receptor were generated, using different methods (Modeller 3 and MOE 4 ) as described in main text and proceeding paper, providing a means to assess consistency in the alignments, the variability within the built structures and which regions of the models had higher and lower confidence associated with them. Further validation and improvement of the homology models was done within the Schrodinger Maestro package, 5 using the induced-fit docking protocol, with an auto generated box size around the residues highlighted by in-house and external SDM as having a large effect on antagonist binding, namely I66 . The resultant docking solutions in combination with the binding data from the thermostabilisation experiments were then used to select the inhouse round of mutants for our BPM experiments; these mutations were chosen so as to best confirm or rule out differing possible binding orientations within the A 2A receptor.
The final docking experiments were guided by ligand SAR and our iterative process of assessing SDM and then designing our own biophysical mapping (BPM) mutants to confirm or rule out possible binding modes. The protein preparation and docking experiments were done within Maestro and the grid generation necessary for docking within Glide. 6 The residues highlighted in SDM experiments (in-house and external) were used to define the cavity of the grid, however, no constraints were added in the grid generation to ensure subsequent dockings were not biased in any way. Glide XP docking was carried out on all of the ligands in question with 10 poses per ligand being stored. The poses were then assessed against the biophysical mapping data and the best solution identified; The BPM studies have been reported elsewhere and analogues 4e and 4g here equate to examples 3b and 3d in the earlier publication.
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Surface Plasmon Resonance Analysis
The assay was run on a Biacore T200 instrument at 25 o C using PBS, 0.05 mM EDTA, 0.1% DDM, 5% DMSO, pH 7.5 as the running buffer. The purified receptor 8, 9 (20 µg/ml in 10 mM MES, 0.1% DDM, pH 6.0) was amine-coupled to sensor chip CM5. Twofold dilution series of each compound (five concentrations) were injected in multicycle or single cycle format. The actual concentrations as well as contact and dissociation times varied between the ligands depending on the kinetics and affinity of interaction. The blank-subtracted data were fitted to 1:1 interaction model to obtain kinetic and affinity constants. With compound 4a, only steady-state affinity data could be obtained due to k a and k d falling beyond the instrument detection range.
The sensorgrams and fits are shown below. S11
